In total, five out of 23 patients had adverse events, including one mild anemia, one GI discomfort, one wheal response, and two liver injury (ALT less than three times the upper limit of normal), which all have been reported in previous RA studies (12, 52). The gene discussed is GPT; the disease is rheumatoid arthritis.